Predictions
Johnson & Johnson
Start price
Target price
Perf. (%)
€174.42
27.04.22
27.04.22
€190.00
27.04.23
27.04.23
-15.38%
27.04.23
27.04.23
Could be worthwhile Investment >10% per year
Market Leader or Top 3
Known brand
Future proof or reliable business model
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€233.45
25.04.22
25.04.22
€250.00
25.04.23
25.04.23
14.61%
26.04.23
26.04.23
Could be worthwhile Investment >10% per year
Fair valuation
Some uniques
Higher risks for its business
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€302.40
13.03.23
13.03.23
-
13.04.23
13.04.23
11.97%
14.04.23
14.04.23
Could be very worthwhile Investment >20% year
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.65
07.04.22
07.04.22
€56.00
07.04.23
07.04.23
-24.58%
08.04.23
08.04.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€248.30
06.04.22
06.04.22
-
06.04.23
06.04.23
18.49%
06.04.23
06.04.23
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€638.60
06.04.22
06.04.22
-
06.04.23
06.04.23
17.91%
06.04.23
06.04.23
Pfizer Inc.
Start price
Target price
Perf. (%)
€47.88
25.03.22
25.03.22
€64.00
25.03.23
25.03.23
-21.14%
27.03.23
27.03.23
Could be worthwhile Investment >10% per year
Intuitive Surgical Inc
Start price
Target price
Perf. (%)
€246.90
30.01.22
30.01.22
€270.00
30.01.23
30.01.23
-9.98%
31.01.23
31.01.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
UnitedHealth Group Inc.
Start price
Target price
Perf. (%)
€407.05
24.01.22
24.01.22
€418.00
24.01.23
24.01.23
10.66%
25.01.23
25.01.23
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€50.01
03.01.22
03.01.22
€78.00
03.01.23
03.01.23
-2.98%
04.01.23
04.01.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Undervalued
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€301.55
28.10.22
28.10.22
-
28.10.23
28.10.23
-10.79%
01.01.23
01.01.23
Risky Investment
Johnson & Johnson
Start price
Target price
Perf. (%)
€149.96
28.12.21
28.12.21
-
28.12.22
28.12.22
10.44%
29.12.22
29.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Good culture
Top 10 in its market
Biogen Inc.
Start price
Target price
Perf. (%)
€208.25
27.12.21
27.12.21
€215.00
27.12.22
27.12.22
23.82%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€52.51
22.12.21
22.12.21
€55.00
22.12.22
22.12.22
-7.45%
23.12.22
23.12.22
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€48.36
06.12.21
06.12.21
€60.00
06.12.22
06.12.22
-0.12%
06.12.22
06.12.22
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€140.70
27.11.21
27.11.21
€160.00
27.11.22
27.11.22
21.35%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Merck & Co. Inc.
Start price
Target price
Perf. (%)
€70.76
26.10.21
26.10.21
€65.00
26.10.22
26.10.22
38.64%
27.10.22
27.10.22
Could be worthwhile Investment >10% per year
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€62.08
13.10.22
13.10.22
-
-
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€56.78
04.02.22
04.02.22
€46.00
04.02.23
04.02.23
18.67%
13.10.22
13.10.22
Top 10 in its market
Good rating
Medium risks for its business
Bad culture
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Henry Schein Inc.
Start price
Target price
Perf. (%)
€67.50
29.09.21
29.09.21
€65.00
29.09.22
29.09.22
0.87%
30.09.22
30.09.22
Could be worthwhile Investment >10% per year